The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-Imino-7-phenethyl-5,6-diphenyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)butan-1-ol ID: ALA5209288
PubChem CID: 51035457
Max Phase: Preclinical
Molecular Formula: C30H30N4O
Molecular Weight: 462.60
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(CCc3ccccc3)c2ncn1CCCCO
Standard InChI: InChI=1S/C30H30N4O/c31-29-27-26(24-14-6-2-7-15-24)28(25-16-8-3-9-17-25)34(20-18-23-12-4-1-5-13-23)30(27)32-22-33(29)19-10-11-21-35/h1-9,12-17,22,31,35H,10-11,18-21H2
Standard InChI Key: QVWKCHUPLIHDIM-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
-2.2289 0.9182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5144 1.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7999 0.9182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7999 0.0929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0851 -0.3197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6295 0.0929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4143 -0.1621 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6279 -0.9590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8994 0.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7244 0.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1387 -0.2121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9633 -0.2121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3724 0.5044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9598 1.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1372 1.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4144 1.1731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6279 1.9701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4282 2.1845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6370 2.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0554 3.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2583 3.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0446 2.5537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6295 0.9182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0851 1.3308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0851 2.1559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4248 -1.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6383 -1.9695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4352 -2.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6473 -2.9780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0638 -3.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2704 -3.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0524 -2.5554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9433 1.3307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6579 0.9182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3724 1.3308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
9 7 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
16 9 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 17 2 0
23 16 1 0
6 23 2 0
23 24 1 0
3 24 1 0
24 25 2 0
8 26 1 0
26 27 1 0
28 27 2 0
29 28 1 0
30 29 2 0
31 30 1 0
32 31 2 0
27 32 1 0
1 33 1 0
33 34 1 0
34 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 462.60Molecular Weight (Monoisotopic): 462.2420AlogP: 5.67#Rotatable Bonds: 9Polar Surface Area: 66.83Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.71CX LogP: 5.62CX LogD: 4.32Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -0.50
References 1. Frankowski KJ, Patnaik S, Wang C, Southall N, Dutta D, De S, Li D, Dextras C, Lin YH, Bryant-Connah M, Davis D, Wang F, Wachsmuth LM, Shah P, Williams J, Kabir M, Zhu E, Baljinnyam B, Wang A, Xu X, Norton J, Ferrer M, Titus S, Simeonov A, Zheng W, Mathews Griner LA, Jadhav A, Aubé J, Henderson MJ, Rudloff U, Schoenen FJ, Huang S, Marugan JJ.. (2022) Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis., 65 (12.0): [PMID:35696646 ] [10.1021/acs.jmedchem.2c00204 ]